Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Nom du journal : Therap Adv Gastroenterol
Année : 2019
Volume : 12
Page de départ : 1756284819878660